Abstract:Background: Liver metastasis is one of the most common causes of death in patients with colorectal cancer. Therefore, improving the treatment effect of liver metastatic carcinoma of colorectal cancer is also one of the effective ways to improve the survival time of patients with colorectal cancer. The main treatment method for liver metastasis of colorectal cancer is preoperative neoadjuvant chemotherapy through intravenous administration. However, no one has reported a conversion therapy approach for the treatment of colorectal cancer liver metastases patients through arterial infusion chemotherapy combined with targeted agents and PD-1 monoclonal antibody. This case reports a conversion therapy method of liver metastases of colorectal cancer by hepatic arterial infusion chemotherapy (HAIC), sintilimab injection combined with lenvatinib to achieve radical resection of liver metastatic carcinoma after treatment. Case presentation: The patient was a 69-year-old man who had previously undergone laparoscopic left hemicolectomy for descending colorectal cancer and multiple interventional and surgical treatments for hepatocellular carcinoma. During this treatment, the patient underwent radiological and serological tests, and primary liver cancer was considered at the initial diagnosis stage. Therefore, this liver malignant tumor lesion was treated according to the primary liver cancer treatment protocol before surgical resection. Therefore, the patient received HAIC combined with sintilimab injection and lenvatinib. After three treatment cycles, radiological examination showed no obvious tumor activity, alpha-fetoprotein (AFP) decreased to normal, protein induced by vitamin K absence or antagonist II (PIVKA II) decreased significantly, and the curative effect was evaluated as complete remission. Subsequently, we performed surgical resection of this liver lesion. The pathological response of left lobe tumor was partial remission (PR). Most of the tumors were necrotic and the necrosis rate was greater than 95%. A small amount of live tumor tissue remains (<5%). The pathological classification of this tumor was confirmed as moderately differentiated adenocarcinoma by immunohistochemical staining of multiple tumor indicators in the pathology department. No significant adverse drug events were observed in this patient during treatment. Conclusion: Hepatic arterial infusion chemotherapy combined with sintilimab injection and lenvatinib conversion therapy provides the opportunity for radical surgical resection of colorectal cancer liver metastases.

A case report about sigmoid colon carcinoma with invading the bladder and simultaneous multiple liver metastases

Multidisciplinary Evaluation of Locally Advanced Leiomyosarcoma in the Lower Rectum: a Case Report and Literature Review

Successful Treatment of Colorectal Liver Metastasis Harboring Intrahepatic Cholangiocarcinoma

The Management of Colorectal Cancer with Synchronous Liver Metastases

Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report

Radiotherapy combined with cytokine-induced killer cell therapy for liver metastasis from rectal cancer: A case report

Case Report: Cetuximab in Combination With Chemotherapy for the Treatment of Multifocal Hepatic Metastases From Colorectal Cancer Guided by Genetic Tests

Rectal Cancer with Inguinal Lymph Nodes Metastasis Treated by Multidisciplinary Team

Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases

Synchronous Isolated Splenic Metastasis from Cancer of Hepatic Flexure of Colon A Case Report

Immunotherapy Combined with Local Therapy in the Late-Line Treatment of Repair-Proficient (pmmr)/microsatellite Stable (MSS) Metastatic Colorectal Cancer

[A clinical study on multi-disciplinary team and surgery for resectable colorectal cancer with liver metastases].

Case Report: MSS colorectal extrahepatic (non-liver) metastases as the dominant population for immunotherapy combined with multi-target tyrosine kinase inhibitors

Two Case Reports of Colon Cancer Peritoneal Metastases Treated by Multidisciplinary Team

Multi-modality Treatment of Colorectal Liver Metastases.

Multidisciplinary approach of liver metastases from colorectal cancer

[Successful treatment of advanced sigmoid colon cancer with liver metastases with cetuximab monotherapy as first-line treatment-a case report]

Lung adenocarcinoma with bladder metastasis: A case report and literature review

Treatment progression in colorectal cancer liver metastasis

3D laparoscopic treatment of bladder cancer with pelvic multi-organ invasion: a case report and literature review

Successful treatment of breast metastasis from primary transverse colon cancer: A case report